Search Results - "MIYAZATO, Paola"
-
1
Identification and characterization of a novel enhancer in the HTLV-1 proviral genome
Published in Nature communications (03-05-2022)“…Human T-cell leukemia virus type 1 (HTLV-1) is a retrovirus that causes adult T-cell leukemia/lymphoma (ATL), a cancer of infected CD4 + T-cells. There is both…”
Get full text
Journal Article -
2
1mΨ influences the performance of various positive-stranded RNA virus-based replicons
Published in Scientific reports (31-07-2024)“…Self-amplifying RNAs (saRNAs) are versatile vaccine platforms that take advantage of a viral RNA-dependent RNA polymerase (RdRp) to amplify the messenger RNA…”
Get full text
Journal Article -
3
The retrovirus HTLV-1 inserts an ectopic CTCF-binding site into the human genome
Published in Proceedings of the National Academy of Sciences - PNAS (15-03-2016)“…Human T-lymphotropic virus type 1 (HTLV-1) is a retrovirus that causes malignant and inflammatory diseases in ∼10% of infected people. A typical host has…”
Get full text
Journal Article -
4
Safety and immunogenicity of parvovirus B19 virus-like particle vaccine lacking phospholipase A2 activity
Published in Vaccine (06-10-2022)“…•⊿PLA2 B19 VLPs-immunization did not cause inflammation in mice.•B19 PLA2 domain does not constitute an important human CD4+ T cell epitope.•⊿PLA2 B19 VLPs…”
Get full text
Journal Article -
5
Fusion of parvovirus B19 receptor-binding domain and pneumococcal surface protein A induces protective immunity against parvovirus B19 and Streptococcus pneumoniae
Published in Vaccine (23-08-2021)“…•B19 RBD alone could not induce neutralizing antibodies due to poor T cell-activation.•RBD-PspA enhanced immunogenicity of RBD, generating parvovirus…”
Get full text
Journal Article -
6
HTLV-1 bZIP factor induces T-cell lymphoma and systemic inflammation in vivo
Published in PLoS pathogens (01-02-2011)“…Human T-cell leukemia virus type 1 (HTLV-1) is the causal agent of a neoplastic disease of CD4+ T cells, adult T-cell leukemia (ATL), and inflammatory diseases…”
Get full text
Journal Article -
7
HIV-1 DNA-capture-seq is a useful tool for the comprehensive characterization of HIV-1 provirus
Published in Scientific reports (23-08-2019)“…Regardless of recent advances in the development of anti-retroviral drugs, it is still extremely difficult to eradicate HIV-1 from infected individuals. The…”
Get full text
Journal Article -
8
HTLV-1 bZIP Factor Enhances T-Cell Proliferation by Impeding the Suppressive Signaling of Co-inhibitory Receptors
Published in PLoS pathogens (03-01-2017)“…Human T-cell leukemia virus type 1 (HTLV-1) causes adult T-cell leukemia-lymphoma (ATL) and inflammatory diseases. To enhance cell-to-cell transmission of…”
Get full text
Journal Article -
9
The Nature of the HTLV-1 Provirus in Naturally Infected Individuals Analyzed by the Viral DNA-Capture-Seq Approach
Published in Cell reports (Cambridge) (15-10-2019)“…The retrovirus human T-cell leukemia virus type 1 (HTLV-1) integrates into the host DNA, achieves persistent infection, and induces human diseases. Here, we…”
Get full text
Journal Article -
10
HTLV-1 bZIP factor induces inflammation through labile Foxp3 expression
Published in PLoS pathogens (01-09-2013)“…Human T-cell leukemia virus type 1 (HTLV-1) causes both a neoplastic disease and inflammatory diseases, including HTLV-1-associated myelopathy/tropical spastic…”
Get full text
Journal Article -
11
HTLV-1 contains a high CG dinucleotide content and is susceptible to the host antiviral protein ZAP
Published in Retrovirology (16-12-2019)“…Human T cell leukaemia virus type 1 (HTLV-1) is a retrovirus associated with human diseases such as adult T-cell leukaemia/lymphoma and HTLV-1 associated…”
Get full text
Journal Article -
12
Protocol to isolate temperature-sensitive SARS-CoV-2 mutants and identify associated mutations
Published in STAR protocols (16-06-2023)“…An inability to proliferate at high temperatures typically gives viruses an attenuated phenotype. Here, we present a protocol to obtain and isolate…”
Get full text
Journal Article -
13
Human T-cell leukemia virus type 1 and Foxp3 expression: viral strategy in vivo
Published in International immunology (01-08-2014)“…Human T-cell leukemia virus type 1 (HTLV-1) is the causal agent of adult T-cell leukemia (ATL) and inflammatory diseases, including HTLV-1-associated…”
Get full text
Journal Article -
14
Transcriptional and Epigenetic Regulatory Mechanisms Affecting HTLV-1 Provirus
Published in Viruses (16-06-2016)“…Human T-cell leukemia virus type 1 (HTLV-1) is a retrovirus associated with human diseases, such as adult T-cell leukemia (ATL) and HTLV-1-associated…”
Get full text
Journal Article -
15
Clonality of HIV-1– and HTLV-1–Infected Cells in Naturally Coinfected Individuals
Published in The Journal of infectious diseases (18-01-2022)“…Abstract Background Coinfection with human immunodeficiency virus type 1 (HIV-1) and human T-cell leukemia virus type 1 (HTLV-1) diminishes the value of the…”
Get full text
Journal Article -
16
Impact of HIV-1 infection pathways on susceptibility to antiviral drugs and on virus spread
Published in Virology (New York, N.Y.) (01-10-2015)“…Abstract The infection routes of HIV-1 can affect several viral properties, including dissemination, pathogenesis, and immune evasion. In this study, we…”
Get full text
Journal Article -
17
IL-2/IL-2 Receptor Pathway Plays a Crucial Role in the Growth and Malignant Transformation of HTLV-1-Infected T Cells to Develop Adult T-Cell Leukemia
Published in Frontiers in microbiology (06-03-2020)“…T cells infected with human T-cell leukemia virus type 1 (HTLV-1) transform into malignant/leukemic cells and develop adult T-cell leukemia (ATL) after a long…”
Get full text
Journal Article -
18
Dynamics and mechanisms of clonal expansion of HIV-1-infected cells in a humanized mouse model
Published in Scientific reports (31-07-2017)“…Combination anti-retroviral therapy (cART) has drastically improved the clinical outcome of HIV-1 infection. Nonetheless, despite effective cART, HIV-1…”
Get full text
Journal Article -
19
Versatile live-attenuated SARS-CoV-2 vaccine platform applicable to variants induces protective immunity
Published in iScience (18-11-2022)“…Live-attenuated vaccines are generally highly effective. Here, we aimed to develop one against SARS-CoV-2, based on the identification of three types of…”
Get full text
Journal Article -
20
Correction: HTLV-1 bZIP Factor Enhances T-cell Proliferation by Impeding the Suppressive Signaling of Co-inhibitory Receptors
Published in PLoS pathogens (01-02-2017)“…[This corrects the article DOI: 10.1371/journal.ppat.1006120.]…”
Get full text
Journal Article